NK Cell Immunotherapy for Solid Tumors Advances, but Cardiac Safety Questions Remain
A new review maps the rapid rise of NK cell immunotherapy for solid tumors and warns that its cardiovascular safety ...
A new review maps the rapid rise of NK cell immunotherapy for solid tumors and warns that its cardiovascular safety ...
A new review maps the engineering strategies, from dual-target receptors to tumor microenvironment remodeling, that could finally bring CAR-T cell ...
Researchers engineered fratricide-resistant CD70-targeting natural killer cells that potently killed patient-derived glioblastoma cells in laboratory and animal models.
Researchers engineered an activation-biased 2B4 costimulatory domain that boosts interferon-gamma production and sustains the killing stamina of CD5-targeting CAR-NK92 cells ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine